| Price | $3.96 |
| Year Range | $3.9 – $16.2 |
| Market Cap | $12M |
| Industry | Medical Devices |
What Is CytoSorbents’s AI Stock Analysis?
CytoSorbents’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks CytoSorbents’s momentum in near-real time.
CytoSorbents (CTSO) has an AltIndex AI Score of 46/100, currently a Hold signal. The AI Score distills CytoSorbents's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
CytoSorbents’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of CytoSorbents — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving CTSO’s AI Score?
Fundamentals
Revenue for the last quarter was $9.6M. This is an increase of 8.68% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 0.17%, suggesting positive year-over-year growth. Net income for the last quarter was $-4.4M. This is an increase of -13.88% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 326.86%, which may be a cause for concern. Ebitda for the last quarter was $-3.3M. This is an increase of -14.04% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 211.51%, which may be a cause for concern.
See CytoSorbents’s earnings and insider transactions.
Technicals
Today's stock price is $3.96. This represents a decrease of 43.43% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 79.06%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $4.06, which is lower than the previous SMA10 of $4.10. This suggests a potential downward trend in price movement. The RSI is 21.3, indicating a potentially oversold (bullish) condition.
See the full technical analysis and price prediction.
Alternative data
The business outlook among employees at CytoSorbents is neutral. CytoSorbents has an estimate of 7,000 visitors to their webpage. The number of visitors is up by 133% in the last couple of months, a bullish trend as this can indicate can increase in customers.
Explore CytoSorbents’s job postings, web traffic and app downloads.
Sentiment & social
CytoSorbents has 380 followers on their Instagram page. The number of followers is up by 14% in the last couple of months, indicating an increased interest in the company. CytoSorbents has 910 followers on their Twitter page, with no meaningful increase or decrese in the last couple of months.
Track CytoSorbents’s market sentiment.
Frequently Asked Questions: CytoSorbents AI Stock Analysis
CytoSorbents's AltIndex AI Score is 46/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates CytoSorbents a Hold (46/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of CytoSorbents — company overview, fundamentals, technicals and alternative data, with a recommendation. See the CTSO AI Score or sign up to read the full thesis.
